Alloy Therapeutics
Alloy Therapeutics is a biotech company that makes medicine by democratizing access to foundational drug discovery platforms and services.
About Alloy Therapeutics
Alloy Therapeutics makes medicine by democratizing access to foundational drug discovery platforms and services. Alloy-Gx, its first platform, is a royalty-free suite of immunocompetent transgenic mice enabling best-in-class in vivo human antibody discovery. Founded in 2017, Alloy Therapeutics is headquartered in Waltham, Massachusetts.
Company Facts
- Headquarters
- Waltham
- Founded
- 2017
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Funding Stage
- late_stage_venture
- Total Funding
- $128,250,000
- Last Funding Type
- series_d
- Last Funding Date
- 2022-10-03
- Website
- alloytx.com
Industries & Categories
Biopharma, Biotechnology, Life Science, Therapeutics
Social Links
Canonical: https://fsome.com/organization/alloy-therapeutics-50624 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.